Global PCSK9 Inhibitors Market Professional Survey Report 2017

August 2017 | 113 pages | ID: G7C3D610FB7EN
QYResearch

Abstracts

This report studies PCSK9 Inhibitors in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Amgen
• Eli Lilly
• Sanofi
• Pfizer
• Novartis
• Roche
• Merck
• Alnylam
• AstraZeneca
• Affiris
• BMS
• Ionis Pharmaceuticals
• Cyon Therapeutics
• Daiichi Sankyo

By types, the market can be split into

• Epatha（Evolocumab）
• Praluent（Alirocumab）
• Bococizumab
• Others

By Application, the market can be split into

• Clinical Application
• Drug Development
• Other

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global PCSK9 Inhibitors Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF PCSK9 INHIBITORS

1.1 Definition and Specifications of PCSK9 Inhibitors
  1.1.1 Definition of PCSK9 Inhibitors
  1.1.2 Specifications of PCSK9 Inhibitors
1.2 Classification of PCSK9 Inhibitors
  1.2.1 Epatha（Evolocumab）
  1.2.2 Praluent（Alirocumab）
  1.2.3 Bococizumab
  1.2.4 Others
1.3 Applications of PCSK9 Inhibitors
  1.3.1 Clinical Application
  1.3.2 Drug Development
  1.3.3 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PCSK9 INHIBITORS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of PCSK9 Inhibitors
2.3 Manufacturing Process Analysis of PCSK9 Inhibitors
2.4 Industry Chain Structure of PCSK9 Inhibitors

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PCSK9 INHIBITORS

3.1 Capacity and Commercial Production Date of Global PCSK9 Inhibitors Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global PCSK9 Inhibitors Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global PCSK9 Inhibitors Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global PCSK9 Inhibitors Major Manufacturers in 2016

4 GLOBAL PCSK9 INHIBITORS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global PCSK9 Inhibitors Capacity and Growth Rate Analysis
  4.2.2 2016 PCSK9 Inhibitors Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global PCSK9 Inhibitors Sales and Growth Rate Analysis
  4.3.2 2016 PCSK9 Inhibitors Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global PCSK9 Inhibitors Sales Price
  4.4.2 2016 PCSK9 Inhibitors Sales Price Analysis (Company Segment)

5 PCSK9 INHIBITORS REGIONAL MARKET ANALYSIS

5.1 North America PCSK9 Inhibitors Market Analysis
  5.1.1 North America PCSK9 Inhibitors Market Overview
  5.1.2 North America 2012-2017E PCSK9 Inhibitors Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E PCSK9 Inhibitors Sales Price Analysis
  5.1.4 North America 2016 PCSK9 Inhibitors Market Share Analysis
5.2 China PCSK9 Inhibitors Market Analysis
  5.2.1 China PCSK9 Inhibitors Market Overview
  5.2.2 China 2012-2017E PCSK9 Inhibitors Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E PCSK9 Inhibitors Sales Price Analysis
  5.2.4 China 2016 PCSK9 Inhibitors Market Share Analysis
5.3 Europe PCSK9 Inhibitors Market Analysis
  5.3.1 Europe PCSK9 Inhibitors Market Overview
  5.3.2 Europe 2012-2017E PCSK9 Inhibitors Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E PCSK9 Inhibitors Sales Price Analysis
  5.3.4 Europe 2016 PCSK9 Inhibitors Market Share Analysis
5.4 Southeast Asia PCSK9 Inhibitors Market Analysis
  5.4.1 Southeast Asia PCSK9 Inhibitors Market Overview
  5.4.2 Southeast Asia 2012-2017E PCSK9 Inhibitors Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E PCSK9 Inhibitors Sales Price Analysis
  5.4.4 Southeast Asia 2016 PCSK9 Inhibitors Market Share Analysis
5.5 Japan PCSK9 Inhibitors Market Analysis
  5.5.1 Japan PCSK9 Inhibitors Market Overview
  5.5.2 Japan 2012-2017E PCSK9 Inhibitors Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E PCSK9 Inhibitors Sales Price Analysis
  5.5.4 Japan 2016 PCSK9 Inhibitors Market Share Analysis
5.6 India PCSK9 Inhibitors Market Analysis
  5.6.1 India PCSK9 Inhibitors Market Overview
  5.6.2 India 2012-2017E PCSK9 Inhibitors Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E PCSK9 Inhibitors Sales Price Analysis
  5.6.4 India 2016 PCSK9 Inhibitors Market Share Analysis

6 GLOBAL 2012-2017E PCSK9 INHIBITORS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E PCSK9 Inhibitors Sales by Type
6.2 Different Types of PCSK9 Inhibitors Product Interview Price Analysis
6.3 Different Types of PCSK9 Inhibitors Product Driving Factors Analysis
  6.3.1 Epatha（Evolocumab） of PCSK9 Inhibitors Growth Driving Factor Analysis
  6.3.2 Praluent（Alirocumab） of PCSK9 Inhibitors Growth Driving Factor Analysis
  6.3.3 Bococizumab of PCSK9 Inhibitors Growth Driving Factor Analysis
  6.3.4 Others of PCSK9 Inhibitors Growth Driving Factor Analysis

7 GLOBAL 2012-2017E PCSK9 INHIBITORS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E PCSK9 Inhibitors Consumption by Application
7.2 Different Application of PCSK9 Inhibitors Product Interview Price Analysis
7.3 Different Application of PCSK9 Inhibitors Product Driving Factors Analysis
  7.3.1 Clinical Application of PCSK9 Inhibitors Growth Driving Factor Analysis
  7.3.2 Drug Development of PCSK9 Inhibitors Growth Driving Factor Analysis
  7.3.3 Other of PCSK9 Inhibitors Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PCSK9 INHIBITORS

8.1 Amgen
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Amgen 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Amgen 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.2 Eli Lilly
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Eli Lilly 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Eli Lilly 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.3 Sanofi
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Sanofi 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Sanofi 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.4 Pfizer
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Pfizer 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Pfizer 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.5 Novartis
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Novartis 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Novartis 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.6 Roche
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Roche 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Roche 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.7 Merck
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Merck 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Merck 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.8 Alnylam
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Alnylam 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Alnylam 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.9 AstraZeneca
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 AstraZeneca 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 AstraZeneca 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.10 Affiris
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Affiris 2016 PCSK9 Inhibitors Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Affiris 2016 PCSK9 Inhibitors Business Region Distribution Analysis
8.11 BMS
8.12 Ionis Pharmaceuticals
8.13 Cyon Therapeutics
8.14 Daiichi Sankyo

9 DEVELOPMENT TREND OF ANALYSIS OF PCSK9 INHIBITORS MARKET

9.1 Global PCSK9 Inhibitors Market Trend Analysis
  9.1.1 Global 2017-2022 PCSK9 Inhibitors Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 PCSK9 Inhibitors Sales Price Forecast
9.2 PCSK9 Inhibitors Regional Market Trend
  9.2.1 North America 2017-2022 PCSK9 Inhibitors Consumption Forecast
  9.2.2 China 2017-2022 PCSK9 Inhibitors Consumption Forecast
  9.2.3 Europe 2017-2022 PCSK9 Inhibitors Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 PCSK9 Inhibitors Consumption Forecast
  9.2.5 Japan 2017-2022 PCSK9 Inhibitors Consumption Forecast
  9.2.6 India 2017-2022 PCSK9 Inhibitors Consumption Forecast
9.3 PCSK9 Inhibitors Market Trend (Product Type)
9.4 PCSK9 Inhibitors Market Trend (Application)

10 PCSK9 INHIBITORS MARKETING TYPE ANALYSIS

10.1 PCSK9 Inhibitors Regional Marketing Type Analysis
10.2 PCSK9 Inhibitors International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of PCSK9 Inhibitors by Region
10.4 PCSK9 Inhibitors Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PCSK9 INHIBITORS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PCSK9 INHIBITORS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of PCSK9 Inhibitors
Table Product Specifications of PCSK9 Inhibitors
Table Classification of PCSK9 Inhibitors
Figure Global Production Market Share of PCSK9 Inhibitors by Type in 2016
Figure Epatha（Evolocumab） Picture
Table Major Manufacturers of Epatha（Evolocumab）
Figure Praluent（Alirocumab） Picture
Table Major Manufacturers of Praluent（Alirocumab）
Figure Bococizumab Picture
Table Major Manufacturers of Bococizumab
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of PCSK9 Inhibitors
Figure Global Consumption Volume Market Share of PCSK9 Inhibitors by Application in 2016
Figure Clinical Application Examples
Table Major Consumers in Clinical Application
Figure Drug Development Examples
Table Major Consumers in Drug Development
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of PCSK9 Inhibitors by Regions
Figure North America PCSK9 Inhibitors Market Size (Million USD) (2012-2022)
Figure China PCSK9 Inhibitors Market Size (Million USD) (2012-2022)
Figure Europe PCSK9 Inhibitors Market Size (Million USD) (2012-2022)
Figure Southeast Asia PCSK9 Inhibitors Market Size (Million USD) (2012-2022)
Figure Japan PCSK9 Inhibitors Market Size (Million USD) (2012-2022)
Figure India PCSK9 Inhibitors Market Size (Million USD) (2012-2022)
Table PCSK9 Inhibitors Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of PCSK9 Inhibitors in 2016
Figure Manufacturing Process Analysis of PCSK9 Inhibitors
Figure Industry Chain Structure of PCSK9 Inhibitors
Table Capacity and Commercial Production Date of Global PCSK9 Inhibitors Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global PCSK9 Inhibitors Major Manufacturers in 2016
Table R&D Status and Technology Source of Global PCSK9 Inhibitors Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global PCSK9 Inhibitors Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of PCSK9 Inhibitors 2012-2017
Figure Global 2012-2017E PCSK9 Inhibitors Market Size (Volume) and Growth Rate
Figure Global 2012-2017E PCSK9 Inhibitors Market Size (Value) and Growth Rate
Table 2012-2017E Global PCSK9 Inhibitors Capacity and Growth Rate
Table 2016 Global PCSK9 Inhibitors Capacity (K Units) List (Company Segment)
Table 2012-2017E Global PCSK9 Inhibitors Sales (K Units) and Growth Rate
Table 2016 Global PCSK9 Inhibitors Sales (K Units) List (Company Segment)
Table 2012-2017E Global PCSK9 Inhibitors Sales Price (USD/Unit)
Table 2016 Global PCSK9 Inhibitors Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of PCSK9 Inhibitors 2012-2017E
Figure North America 2012-2017E PCSK9 Inhibitors Sales Price (USD/Unit)
Figure North America 2016 PCSK9 Inhibitors Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of PCSK9 Inhibitors 2012-2017E
Figure China 2012-2017E PCSK9 Inhibitors Sales Price (USD/Unit)
Figure China 2016 PCSK9 Inhibitors Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of PCSK9 Inhibitors 2012-2017E
Figure Europe 2012-2017E PCSK9 Inhibitors Sales Price (USD/Unit)
Figure Europe 2016 PCSK9 Inhibitors Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of PCSK9 Inhibitors 2012-2017E
Figure Southeast Asia 2012-2017E PCSK9 Inhibitors Sales Price (USD/Unit)
Figure Southeast Asia 2016 PCSK9 Inhibitors Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of PCSK9 Inhibitors 2012-2017E
Figure Japan 2012-2017E PCSK9 Inhibitors Sales Price (USD/Unit)
Figure Japan 2016 PCSK9 Inhibitors Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of PCSK9 Inhibitors 2012-2017E
Figure India 2012-2017E PCSK9 Inhibitors Sales Price (USD/Unit)
Figure India 2016 PCSK9 Inhibitors Sales Market Share
Table Global 2012-2017E PCSK9 Inhibitors Sales (K Units) by Type
Table Different Types PCSK9 Inhibitors Product Interview Price
Table Global 2012-2017E PCSK9 Inhibitors Sales (K Units) by Application
Table Different Application PCSK9 Inhibitors Product Interview Price
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Amgen PCSK9 Inhibitors Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Eli Lilly PCSK9 Inhibitors Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2015 Sanofi PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sanofi PCSK9 Inhibitors Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pfizer PCSK9 Inhibitors Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis PCSK9 Inhibitors Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Roche PCSK9 Inhibitors Business Region Distribution
Table Merck Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Merck PCSK9 Inhibitors Business Region Distribution
Table Alnylam Information List
Table Product A Overview
Table Product B Overview
Table 2016 Alnylam PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Alnylam PCSK9 Inhibitors Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 AstraZeneca PCSK9 Inhibitors Business Region Distribution
Table Affiris Information List
Table Product A Overview
Table Product B Overview
Table 2016 Affiris PCSK9 Inhibitors Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Affiris PCSK9 Inhibitors Business Region Distribution
Table BMS Information List
Table Ionis Pharmaceuticals Information List
Table Cyon Therapeutics Information List
Table Daiichi Sankyo Information List
Figure Global 2017-2022 PCSK9 Inhibitors Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 PCSK9 Inhibitors Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 PCSK9 Inhibitors Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 PCSK9 Inhibitors Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 PCSK9 Inhibitors Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 PCSK9 Inhibitors Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 PCSK9 Inhibitors Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 PCSK9 Inhibitors Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 PCSK9 Inhibitors Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of PCSK9 Inhibitors by Type 2017-2022
Table Global Consumption Volume (K Units) of PCSK9 Inhibitors by Application 2017-2022
Table Traders or Distributors with Contact Information of PCSK9 Inhibitors by Region